Contract 36C26222F0471
Telix Pharmaceuticals Us Inc · Department Of Veterans Affairs · July 18, 2022
Telix Pharmaceuticals Us Inc was awarded a federal contract by Department Of Veterans Affairs on July 18, 2022 for $49,000 of work in pharmaceutical preparation manufacturing. Performance is in San Diego, CA. This is a task or delivery order issued under parent IDIQ 36F79722D026E. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on June 29, 2023. If all options are exercised, the contract could reach $385,000.
Contract details
- PIID
- 36C26222F0471
- Parent IDIQ
- 36F79722D026E
- Award type
- Delivery Order
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- San Diego, CA
- First action
- July 18, 2022
- Latest action
- June 29, 2023
Description
DECREASE MOD - EMERGENCY ILLUCCIX (NUCLEAR MEDICINE) ORDER FOR VA SD - DE-OBLIGATE AND CLOSE
Modification timeline
-
June 29, 2023Mod P00002$-119.0K
-
October 20, 2022Mod P00001MOD - EMERGENCY ILLUCCIX (NUCLEAR MEDICINE) ORDER FOR VA SD$0
-
July 18, 2022Base awardEMERGENCY ILLUCCIX (NUCLEAR MEDICINE) ORDER FOR VA SD$168.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C26222F0471?
Contract 36C26222F0471 is a federal contract awarded to Telix Pharmaceuticals Us Inc by Department Of Veterans Affairs on July 18, 2022 for $49,000 of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 2 times since the base award.
Who won contract 36C26222F0471?
Telix Pharmaceuticals Us Inc won contract 36C26222F0471 from Department Of Veterans Affairs.
How much is contract 36C26222F0471 worth?
Contract 36C26222F0471 has obligated $49,000 to date, with a total potential value of $385,000 if all options are exercised.